298
Views
1
CrossRef citations to date
0
Altmetric
Research Article

An audit to review the characteristics and management of placenta praevia at Aberdeen Maternity Hospital, 2009–2011

&
 

Abstract

Placenta praevia (PP) is an important cause of maternal and fetal morbidity. We reviewed the characteristics and management of PP at the Aberdeen Maternity Hospital (AMH) to evaluate performance. In the years 2009–2011, a total of 60 cases with confirmed PP underwent caesarean section (CS) at the AMH. Two-fifths of cases had previous CS and two-thirds were posterior praevias. Four-fifths were major praevias. Diagnosis was mostly by trans-abdominal scanning (TAS). A little less than two-thirds underwent hospital admission (half of them for antepartum haemorrhage). Most received steroid and ferrous sulphate as appropriate. The majority were delivered at greater than 36 weeks’ gestation. There was good support in theatre by senior obstetricians and anaesthetists. Cell salvage was used in theatre. Overall, the outcomes were good. Improvements could be made on documentation of counselling preoperatively and practice of trans-vaginal scans (TVS) to confirm low lying placentae even at the 20-week scan for better diagnosis, as per the RCOG guidelines.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.